HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Discrimination of human lung neoplasm from normal lung by two target genes.

Abstract
Simple tools for discrimination of lung tissues can be useful in a fast machine-aided diagnosis, for example, by tumor-specific microarrays. We demonstrate that an easy ratio technique, based on the expression levels of only two genes differentially expressed in lung tumor and normal lung samples, allows discrimination of normal and neoplastic lung with a sensitivity of 100% and specificity of 90.5%. DNA microarray analysis of 99 lung tumor samples and 15 normal lung tissues revealed that receptor for advanced glycation end products (RAGE) mRNA is reduced fourfold (p = 7.8 x 10(-11)) and cyclin-B2 mRNA is upregulated twofold (p = 5.9 x 10(-18)) in lung carcinoma compared with normal lung. The microarray-calculated expression ratio of RAGE to cyclin-B2 was used in polymerase chain reaction analysis of 84 independent blinded samples to discriminate tumor and corresponding normal lung tissues. In 94.7% of the samples this quotient correctly distinguished non-small cell lung cancer from normal lung tissue, suggesting the RAGE/cyclin-B2 quotient as a potential means for diagnosis of lung cancer.
AuthorsHans-Stefan Hofmann, Gesine Hansen, Stefan Burdach, Babett Bartling, Rolf-Edgar Silber, Andreas Simm
JournalAmerican journal of respiratory and critical care medicine (Am J Respir Crit Care Med) Vol. 170 Issue 5 Pg. 516-9 (Sep 01 2004) ISSN: 1073-449X [Print] United States
PMID15331390 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CCNB2 protein, human
  • Cyclin B
  • Cyclin B2
  • Genetic Markers
  • Receptor for Advanced Glycation End Products
  • Receptors, Immunologic
Topics
  • Adenocarcinoma (genetics)
  • Carcinoma, Squamous Cell (genetics)
  • Case-Control Studies
  • Cyclin B (genetics)
  • Cyclin B2
  • Feasibility Studies
  • Gene Expression Profiling
  • Genetic Markers
  • Humans
  • Lung Neoplasms (genetics, secondary)
  • Oligonucleotide Array Sequence Analysis
  • Receptor for Advanced Glycation End Products
  • Receptors, Immunologic (genetics)
  • Reproducibility of Results

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: